Miriam Conceicao Souza-Testasicca

Miriam Conceicao Souza-Testasicca

Auto-generated profile, based on publicly available information

Miriam Conceicao Souza-Testasicca

Instituto Federal de Educação, Ciência e Tecnologia de Minas Gerais

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2010 in Acta Tropica
Verified
Journal Article
Closed access
MSMiriam Conceição de Souza
Miriam Conceição de Souza
EAElisângela Aparecida de Assis
Elisângela Aparecida de Assis
RGRodrigo Saar Gomes
Rodrigo Saar Gomes
ESEduardo de Almeida Marques da Silva
Eduardo de Almeida Marques da Silva
MMMaria Norma Melo
Maria Norma Melo
LALuis Carlos Crocco Afonso
Luis Carlos Crocco Afonso

1 August 2014 in Veterinary Parasitology
Verified
Journal Article
Closed access
MTMiriam C. de Souza Testasicca
Miriam C. de Souza Testasicca
MSMariana Silva dos Santos
Mariana Silva dos Santos
LMLeopoldo Marques Machado
Leopoldo Marques Machado
ASAngela Vieira Serufo
Angela Vieira Serufo
DDDaniel Doro
Daniel Doro
AFAna Paula Fernandes
Ana Paula Fernandes

1 June 2013 in Clinical and Vaccine Immunology
Verified
Journal Article
Open access
PDF file
Miguel Angel Chavez FumagalliMiguel Angel Chavez Fumagalli
Miguel Angel Chavez Fumagalli
VMVivian T. Martins
Vivian T. Martins
MTMiriam C. S. Testasicca
Miriam C. S. Testasicca
DLDaniela P. Lage
Daniela P. Lage
LCLourena E. Costa
Lourena E. Costa
ECEDUARDO COELHO
EDUARDO COELHO
In Brazil, the percentage of infected dogs living in areas where canine visceral leishmaniasis (CVL) is endemic ranges from 10 to 62%; however, the prevalence of infection in dogs is probably higher than figures reported from serological studies. In addition, problems with the occurrence of false-positive or false-negative results in the serodiagnosis of CVL have been reported. The present work analyzed the potential of synthetic peptides mapped from hypothetical proteins for improvement of the serodiagnosis ofLeishmania infantuminfection in dogs. From 26 identified leishmanial proteins, eight were selected, considering that no homologies between these proteins and others from trypanosomatide sequence databases were encountered. The sequences of these proteins were mapped to identify linear B-cell epitopes, and 17 peptides were synthesized and tested in enzyme-linked immunosorbent assays (ELISAs) for the serodiagnosis ofL. infantuminfection in dogs. Of these, three exhibited sensitivity and specificity values higher than 75% and 90%, respectively, to differentiateL. infantum-infected animals fromTrypanosoma cruzi-infected animals and healthy animals. SolubleLeishmaniaantigen (SLA) showed poor sensitivity (4%) and specificity (36%) to differentiateL. infantum-infected dogs from healthy andT. cruzi-infected dogs. Lastly, the three selected peptides were combined in different mixtures and higher sensitivity and specificity values were obtained, even when sera fromT. cruzi-infected dogs were used. The study's findings suggest that these three peptides can constitute a potential tool for more sensitive and specific serodiagnosis ofL. infantuminfection in dogs.

25 July 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
AFAmanda Braga Figueiredo
Amanda Braga Figueiredo
MSMíriam Conceição Souza-Testasicca
Míriam Conceição Souza-Testasicca
TMTiago Wilson Patriarca Mineo
Tiago Wilson Patriarca Mineo
LALuis Carlos Crocco Afonso
Luis Carlos Crocco Afonso
Differently from others Leishmania species, infection by the protozoan parasite Leishmania amazonensis is associated with a lack of antigen-specific T-cell responses. Dendritic cells (DC) are essential for the innate immune response and for directing the differentiation of T-helper lymphocytes. Previously, we showed that L. amazonensis infection impairs DC activation through the activation of adenosine A2B receptor, and here we evaluated the intracellular events triggered by this receptor in infected cells. To this aim, bone marrow-derived DC from C57BL/6J mice were infected with metacyclic promastigotes of L. amazonensis. Our results show, for the first time, that L. amazonensis increases the production of cAMP and the phosphorylation of ERK1/2 in infected DC by a mechanism dependent on the A2B receptor. Furthermore, L. amazonensis impairs CD40 expression and IL-12 production by DC and the inhibition of adenylate cyclase, PI3K and ERK1/2 prevent these effects. The increase of ERK1/2 phosphorylation and the inhibition of DC activation by L. amazonensis are independent of PKA. In addition, C57BL/6J mice were inoculated in the ears with metacyclic promastigotes, in the presence of PSB1115, an A2B receptor antagonist. PSB1115 treatment increases the percentage of CD40+ DC on ears and draining lymph nodes. Furthermore, this treatment reduces lesion size and tissue parasitism. Lymph node cells from treated mice produce higher levels of IFN-γ than control mice, without altering the production of IL-10. In conclusion, we suggest a new pathway used by the parasite (A2B receptor - cAMP - PI3K - ERK1/2) to suppress DC activation, which may contribute to the decrease of IFN-γ production following by the deficiency in immune response characteristic of L. amazonensis infection.

1 September 2010 in Memórias do Instituto Oswaldo Cruz
Verified
Journal Article
Open access
PDF file
RGRafaella Fortini Queiroz e Grenfell
Rafaella Fortini Queiroz e Grenfell
EMEduardo A Marques-Da-Silva
Eduardo A Marques-Da-Silva
MSMiriam C Souza-Testasicca
Miriam C Souza-Testasicca
ECEduardo Af Coelho
Eduardo Af Coelho
AFAna Paula Fernandes
Ana Paula Fernandes
SRSimone A Rezende
Simone A Rezende
This study evaluated two vaccine candidates for their effectiveness in protecting BALB/c mice against Leishmania chagasi infection. These immunogenic preparations were composed of Leishmania amazonensis or Leishmania braziliensis antigenic extracts in association with saponin adjuvant. Mice were given three subcutaneous doses of one of these vaccine candidates weekly for three weeks and four weeks later challenged with promastigotes of L. chagasi by intravenous injection. We observed that both vaccine candidates induced a significant reduction in the parasite load of the liver, while the L. amazonensis antigenic extract also stimulated a reduction in spleen parasite load. This protection was associated with a suppression of both interleukin (IL)-10 and IL-4 cytokines by spleen cells in response to L. chagasi antigen. No change was detected in the production of IFN-γ. Our data show that these immunogenic preparations reduce the type 2 immune response leading to the control of parasite replication.

1 August 2016 in Biomedical Journal
Verified
Journal Article
Open access
AFAmanda Braga de Figueiredo
Amanda Braga de Figueiredo
MSMiriam Conceicao Souza-Testasicca
Miriam Conceicao Souza-Testasicca
LALuis Carlos Crocco Afonso
Luis Carlos Crocco Afonso
Infection by protozoan parasites is part of the most common Tropical Neglected Diseases. In the case of leishmaniasis, several millions of people are at risk of contracting the disease. In spite of innumerous studies that elucidated the immune response capable of killing the parasite, the understanding of the evasion mechanisms utilized by the parasite to survive within the very cell responsible for its destruction is still incomplete. In this review, we offer a new approach to the control of the immune response against the parasite. The ability of the parasite to modulate the levels of extracellular ATP and adenosine either by directly acting on the levels of these molecules or by inducing the expression of CD39 and CD73 on the infected cell may influence the magnitude of the immune response against the parasite contributing to its growth and survival.